Gibson Christopher

CIK 00018563692 companiesSALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001856369

Recent Transactions

50 trades

Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-03-09−20,000→ 4,523,334 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-03-09−20,000→ 906,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-03-09+20,000→ 926,556 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2026-03-03+53,913→ 53,913 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2026-03-03+73,087→ 73,087 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-19$3.46/sh−40,000→ 906,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-02-19−40,000→ 4,543,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-19+40,000→ 946,556 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-17$3.49/sh−27,265→ 906,556 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-06$3.56/sh−10,364→ 933,821 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-06+30,346→ 944,185 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-02-04−40,000→ 4,583,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-04+40,000→ 953,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-04$4.12/sh−40,000→ 913,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-20$4.47/sh−40,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-01-20−40,000→ 4,623,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-20+40,000→ 953,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-01-05−60,000→ 4,663,334 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-05$4.25/sh−40,000→ 933,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-05+60,000→ 973,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-05−20,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-12-19−40,000→ 4,723,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-19+40,000→ 953,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-19$4.50/sh−40,000→ 913,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04$4.63/sh−40,000→ 933,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04−20,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-12-04−60,000→ 4,763,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04+60,000→ 973,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-19+40,000→ 953,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-11-19−40,000→ 4,823,334 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-19$4.16/sh−40,000→ 913,839 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-17$4.14/sh−40,390→ 913,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-04−20,000→ 954,229 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-04$5.21/sh−40,000→ 974,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-11-04−60,000→ 4,863,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-11-04+60,000→ 1,014,229 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-23$5.70/sh−100,000→ 954,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-10-23−100,000→ 4,923,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-23+100,000→ 1,054,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-10+120,000→ 1,074,229 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-10−20,000→ 954,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-10-10−120,000→ 5,133,034 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-10-10$6.04/sh−100,000→ 974,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-09-25−0→ 5,253,034 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-25+100,000→ 1,054,229 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-25$4.76/sh−100,000→ 954,229 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-10$4.71/sh−100,000→ 974,229 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-10−20,000→ 954,229 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-09-10−120,000→ 5,253,034 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-09-10+120,000→ 1,074,229 total

Companies

Recent Filings

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov